Related references
Note: Only part of the references are listed.Immunogenicity and safety of a two-dose schedule of whole-virion and AS03A-adjuvanted 2009 influenza A (H1N1) vaccines: a randomised, multicentre, age-stratified, head-to-head trial
Karl G. Nicholson et al.
LANCET INFECTIOUS DISEASES (2011)
Evaluation of Adjuvanted Pandemic H1N12009 Influenza Vaccine After One and Two Doses in Young Children
David W. Scheifele et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2011)
Immunogenicity and safety of influenza A (H1N1) 2009 monovalent inactivated split vaccine in Korea
Hee Jin Cheong et al.
VACCINE (2011)
Immunogenicity of a Monovalent 2009 Influenza A(H1N1) Vaccine in Infants and Children A Randomized Trial
Terry Nolan et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
A Rapid Immune Response to 2009 Influenza A(H1N1) Vaccines in Adults: A Randomized, Double-Blind, Controlled Trial
Jiang Wu et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Immune response after a single vaccination against 2009 influenza A H1N1 in USA: a preliminary report of two randomised controlled phase 2 trials
Eric Plennevaux et al.
LANCET (2010)
Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebo-controlled trial
Xiao-Feng Liang et al.
LANCET (2010)
Immunogenicity and safety of AS03-adjuvanted 2009 influenza A H1N1 vaccine in children 6-35 months
Alfonso Carmona et al.
VACCINE (2010)
Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre study
Claire S. Waddington et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
Trial of 2009 Influenza A (H1N1) Monovalent MF59-Adjuvanted Vaccine.
Tristan W. Clark et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Future of flu vaccines Expediting clinical trials in a pandemic
Andrew J. Pollard et al.
BRITISH MEDICAL JOURNAL (2009)
Ocular and respiratory symptoms attributable to inactivated split influenza vaccine: Evidence from a controlled trial involving adults
DW Scheifele et al.
CLINICAL INFECTIOUS DISEASES (2003)
Unique roles of a data and safety monitoring board in vaccine safety trials with compressed timelines and urgent implications
D Scheifele et al.
CONTROLLED CLINICAL TRIALS (2003)
Share Paper
